ATE.TO: Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…
By David Bautz, PhD
OTC:ATBPF | TSX:ATE.TO
READ THE FULL ATE.TO RESEARCH REPORT
ATE.TO: First Human PK/PD Studies Underway in Otenaproxesul’s Post-Operative Pain Program…
By David Bautz, PhD
OTC:ATBPF | TSX:ATE.TO
READ THE FULL ATE.TO RESEARCH REPORT
ATE.TO: Pivoting to Acute Pain Relief for Otenaproxesul…
By David Bautz, PhD
OTC:ATBPF | TSX:ATE.TO
READ THE FULL ATE.TO RESEARCH REPORT
ATE.TO: Unexpected Liver Enzyme Elevations Leads to Pause in AME Trial…
By David Bautz, PhD
OTC:ATBPF | TSX:ATE.TO
READ THE FULL ATE.TO RESEARCH REPORT